Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-02-002230
Filing Date
2002-04-16
Accepted
2002-04-16 00:00:00
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT c68892e10-k.txt 10-K 210545
3 PROMISSORY NOTE c68892ex10-17.txt EX-10.17 40321
4 PROCESSING AGREEMENT c68892ex10-18.txt EX-10.18 37767
5 SUBORDINATION, STANDBY AND INTERCREDITOR AGREEMENT c68892ex10-19.txt EX-10.19 20240
6 SUBORDINATION AND INTERCREDITOR AGREEMENT c68892ex10-20.txt EX-10.20 16965
7 WAIVER LETTER c68892ex10-21.txt EX-10.21 5990
8 SUPPLY AGREEMENT c68892ex10-22.txt EX-10.22 72209
9 SUBSIDIARIES OF THE COMPANY c68892ex21-1.txt EX-21.1 373
  Complete submission text file 0000950137-02-002230.txt   406826
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069 8472363800
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-13976 | Film No.: 02612852
SIC: 2834 Pharmaceutical Preparations